These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7285242)

  • 1. pH-dependent interaction of microsomal cytochrome P-450 with substrates. I. Effect of pH upon the interaction of exogenous substrates with membrane-bound cytochrome P-450.
    Hachino Y; Matsubara T; Hagihara B
    Chem Biol Interact; 1981 Oct; 37(1-2):181-90. PubMed ID: 7285242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic aminopyrine N-demethylase system: interaction of aminopyrine with microsomal cytochrome P-450.
    Hachino Y; Matsubara T; Hagihara B
    Jpn J Pharmacol; 1981 Dec; 31(6):911-20. PubMed ID: 7334736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucose administration on various rat hepatic constituents and on the spectral binding of hexobarbital and methadone to rat hepatic cytochrome P450.
    Buchholz J; Strother A; Fraser IM
    Pharmacology; 1989; 38(2):129-36. PubMed ID: 2727049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the spectral interactions of fusarin C with rat liver microsomal cytochrome P-450.
    Gelderblom WC; Swart P; Kramer PS
    Xenobiotica; 1988 Sep; 18(9):1005-14. PubMed ID: 3227702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the substrate analogue of cytochrome P-450 and mixed function oxidases.
    Popova VI; Leonova IN; Weiner LM; Salganik RI
    Biochem Pharmacol; 1982 Jun; 31(11):1993-8. PubMed ID: 6288047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lipid peroxide decomposition by compounds which bind with cytochrome p-450.
    Islam SI; Zaher FA
    Life Sci; 1983 Sep; 33(12):1113-8. PubMed ID: 6888166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aromatic nitro compounds on oxidative metabolism by cytochrome P-450 dependent enzymes.
    Sternson LA; Gammans RE
    J Med Chem; 1976 Jan; 19(1):174-7. PubMed ID: 1246040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of puromycin on binding and on metabolism in vitro of substrates by rat liver microsomes.
    Soliman MR; Wade AE
    Biochem Pharmacol; 1972 Oct; 21(19):2652-6. PubMed ID: 4661623
    [No Abstract]   [Full Text] [Related]  

  • 10. Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital.
    Bast A; Noordhoek J
    Biochem Pharmacol; 1980 Mar; 29(5):747-51. PubMed ID: 20227951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between type I and type II substrate binding to cytochrome P-450 by variation of temperature.
    Misselwitz R; Jänig GR; Rein H; Buder E; Zirwer D; Ruckpaul K
    Acta Biol Med Ger; 1976; 35(5):K 19-25. PubMed ID: 983603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of spin-labelled substrate analogs for a comparative study of microsomal cytochrome P-450 and P-448].
    Popova VI; Vaĭner LM; Gorshkova II; Gromova OA; Liakhovich VV
    Biokhimiia; 1985 Jan; 50(1):53-62. PubMed ID: 2983784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of action of cytochrome P-450. Spectral intermediates in the reaction of P-450LM2 with peroxy compounds.
    Blake RC; Coon MJ
    J Biol Chem; 1980 May; 255(9):4100-11. PubMed ID: 7372668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of phospholipids on the differential spectra of the binding of microsomal cytochrome P-450 with substrates].
    Diatlovitskaia EV; Petkova DKh; Lemenovskaia AF; Bergel'son LD
    Biokhimiia; 1984 Apr; 49(4):551-5. PubMed ID: 6733159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased content of cytochrome P-450 and 4-methylpyrazole binding spectrum after 4-methylpyrazole treatment.
    Feierman DE; Cederbaum AI
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1076-81. PubMed ID: 3977903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the reactivity of microsomal cytochrome P-450 toward drugs and exogenous ligands.
    Miyake Y; Takayama N; Fukuyama M; Nonaka Y
    J Biochem; 1977 Jul; 82(1):239-49. PubMed ID: 893382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition between hydrocarbon and barbiturate for spectral binding to hepatic cytochrome P-450. Inferences concerning spin state of the enzyme.
    Backes WL; Means M; Canady WJ
    J Biol Chem; 1984 Aug; 259(16):10092-9. PubMed ID: 6469956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.